Okay. Thank you, Mike. Turning to our quarterly results if you are looking at the slides, I'll generally be talking to Slide 3. Third quarter results were generally positive. As we mentioned in our earnings release, we generated a 42% increase in service operating income, which drove our consolidated results. The segment delivered double-digit growth of 10.5%. This represents 27 consecutive year-over-year revenue growth, quarters of year-over-year revenue growth for Transcat. From a consolidated revenue growth perspective, our double-digit service growth was offset by a decline in Distribution segment revenue resulting from a continued weakness in the industrial environment, particularly the direct and indirect impact from the weakness in oil and gas and the strength of the U.S. dollar. All in all, a positive performance in this challenging environment can be highlighted by our 30% increase in net income and the strong growth in cash from operation as we generated $7.4 million year-to-date, up significantly from $1.2 million in the same period last year. Let me walk you through our segment performances. Our Service segment continues to be our primary growth engine from a revenue and earnings perspective. For the quarter, Service contributed a 46% of our total revenue. Service revenue was up nearly 11% to 13.9 million, a record third quarter for the segment. Segment operating income increased 42%, and operating margin expanded 120 basis points. Strong operating leverage continues to have a very favorable effect on our overall profitability. Despite a decline in industrial output, we continue to perform well on the organic sales front. Significant life science growth, both in pharmaceuticals and medical devices have offset service softness in the general industry sector, including markets related to oil and gas. So we continue to execute the strategic plan and to grow our service business in particular driving revenue in the life science sector. On the acquisition front, we have done an outstanding job not only of acquiring companies, but acquiring the right companies at the right valuation. Mostly recently, in fact last week, we increased our life science capabilities and expertise in Montreal with the acquisition of Dispersion Laboratory as we continue to fortify and grow our leading position in Canada. Dispersion is the only laboratory in Canada performing robotic mass calibrations, which we anticipate will be an important differentiator as we look to grow our life science revenue in Canada. Spectrum Technologies, which closed after our quarter end and right at the end of December, increased our geographic footprint and capabilities as we now offer a full suite of biomed services throughout the United States. Spectrum brings annualized revenue of almost $6 million and operating income margins in the 20% range. It is the largest acquisition we've made in several years, and we love the strategic fit as we drive the growth of our life science portfolio. Moving forward, the acquisition pipeline remains strong and we maintain the financial flexibility to move fast when we identify the right opportunities. Moving on to Distribution, we all know the industrial macros have been a challenge over the past couple of quarters. About half of our year-over-year distribution decline relates to the turmoil in the oil and gas market. Also, the strong U.S. dollar has certainly had a derivative effect on distribution revenues as well. That said, we are encouraged that the rate of decline in Q3 slowed, and maybe nearing the bottom. Our consolidated performance in the phase of economic challenges can be highlighted by three major developments which give us cause for encouragement as we drive through Q4 and enter into fiscal 2017. Number one, rapid deployment of web-oriented technology upgrades that allow our Distribution business to compete more effectively on the web, and our Service segment to strengthen its value proposition; number two, successful completion and transition of numerous strategic acquisitions; and three, a host of new diversified programs in both segments of our business, including SKU expansion, ensuring [ph] rentals and value-added options on many of our products, all of which have generated meaningful operating income. We believe that economic slowdowns are some of the best times to make our most significant strides, and we will continue to make progress in positioning the company for a strong future. With that, I'm going to turn things over to John to discuss the quarterly results.